UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
June
06, 2025
Commission
File Number 001-14978
SMITH & NEPHEW plc
(Registrant’s
name)
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F ✓
Form 40-F
__
SMITH & NEPHEW PLC
6 June 2025
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
This announcement is made in accordance with the UK Market Abuse
Regulation (Regulation (EU) 596/2014, as it forms part of domestic
law by virtue of the European Union (Withdrawal) Act
2018).
On 6 June 2025, Smith & Nephew plc (the "Company") received
notification of the following transactions as detailed
below.
|
Reason for the notification
|
|
|
Initial
notification/Amendment
|
Initial
notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
Name
|
Smith
& Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc SPON ADR American Depositary Shares
(ADS)
|
|
Identification
code
|
ISIN:
US83175M2052
|
|
Nature
of the transaction
|
Director and PDMRs are participants of the Company's Employee Stock
Purchase Plan, which purchased American Depository Shares through
the Company's Dividend Re-Investment Plan following the 2024 final
dividend payment on 28 May 2025.
|
|
Date of
Transaction
|
2025-06-04
|
|
Place
of Transaction
|
New
York Stock Exchange
|
|
Name
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
|
Craig
Gaffin
(President,
Global Orthopaedics)
|
PDMR
|
29.3442
|
33.73275
|
N/A
Single Transaction
|
|
Mizanu
Kebede
(Chief
Quality & Regulatory Affairs Officer)
|
PDMR
|
29.3442
|
19.37144
|
N/A
Single Transaction
|
|
Deepak
Nath
(Chief
Executive Officer)
|
Director
|
29.3442
|
35.79737
|
N/A
Single Transaction
|
|
Paul
Connolly
(President,
Global Operations)
|
PDMR
|
29.3442
|
35.64110
|
N/A
Single Transaction
|
|
Scott
Schaffner
(President,
Sports Medicine)
|
PDMR
|
29.3442
|
46.62612
|
N/A
Single Transaction
|
Philip Horner
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
June 06, 2025
|
By:
|
/s/
Helen Barraclough
|
|
|
|
Helen
Barraclough
|
|
|
|
Company
Secretary
|